文献速递血栓与止血

骨髓来源间充质干细胞缺陷在免疫性血小板减少症患者CD8+ CD28-抑制性T细胞诱导中的作用及相关机制

Role of bone marrow-derived mesenchymal stem cell defects in CD8+ CD28- suppressor T-lymphocyte induction in patients with immune thrombocytopenia and associated mechanisms.
PubMed 文献 · Br J Haematol · 2020-07-16

研究比较免疫性血小板减少症(ITP)患者与正常对照骨髓来源间充质干细胞(BM-MSC)诱导抑制性T(Ts)细胞的能力及机制。共培养显示BM-MSC可提升Ts细胞比例和功能,但ITP患者效率低于正常对照。阻断IL-6部分逆转诱导,外源性IL-6下调Ts细胞凋亡;全反式维甲酸预处理促进诱导,脐带来源MSC可改善ITP患者Ts细胞数量和功能障碍。

要点

  • ITP患者BM-MSC诱导CD8+ CD28- Ts细胞的比例和功能效率低于正常对照。
  • 阻断IL-6可部分逆转BM-MSC对Ts细胞的诱导,外源性IL-6下调Ts细胞凋亡。
  • 全反式维甲酸预处理促进BM-MSC诱导Ts细胞,脐带来源MSC改善ITP患者Ts细胞数量与功能障碍。

核心结论

  • BM-MSC诱导Ts细胞缺陷参与ITP发病机制,外源性脐带来源MSC可能对ITP治疗有用。

研究设计与样本

  • 比较ITP患者与正常对照的骨髓来源间充质干细胞(BM-MSC)诱导Ts细胞的能力并探讨机制,采用CD8+ T细胞与BM-MSC共培养、阻断实验及预处理干预。

主要发现

  • CD8+ T细胞与BM-MSC共培养后Ts细胞比例和功能升高,但ITP患者中该效率低于正常对照。
  • 阻断白细胞介素6(IL-6)可部分逆转BM-MSC对Ts细胞的诱导,添加外源性IL-6下调Ts细胞凋亡。
  • BM-MSC增强Ts细胞的IL-10分泌和抑制能力,而ITP患者中IL-6分泌、Ts细胞IL-10表达调控能力及BM-MSC增强Ts细胞抑制功能的效率均降低。
  • 全反式维甲酸预处理促进BM-MSC诱导Ts细胞百分比,脐带来源(UC)MSC有效改善ITP患者Ts细胞数量和功能障碍。

临床怎么用

  • 作者认为外源性脐带来源间充质干细胞可能对ITP治疗有用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many immune dysfunctions participate in immune thrombocytopenia (ITP) pathogenesis, including numeric and functional defects in suppressor T (Ts) cells and immune-regulation abnormalities in mesenchymal stem cells (MSCs). Recent studies showed that MSCs can promote Ts cell differentiation. Thus, we compared the Ts cell induction ability of bone marrow-derived MSCs (BM-MSCs) between patients with ITP and normal controls (NCs), and examined the mechanism of this difference. Co-culture of CD8+ T cells with BM-MSCs revealed that BM-MSCs elevated Ts cell percentage and function, but the efficiency was lower in patients with ITP than in NCs. Blockade experiments showed that blockade of interleukin 6 (IL-6) partially reversed Ts cell induction by BM-MSCs. Addition of exogenous IL-6 down-regulated Ts cell apoptosis. Moreover, BM-MSCs enhanced IL-10 secretion and inhibition ability of Ts cells. IL-6 secretion, regulatory abilities of IL-10 expression in Ts cells, and the enhanced efficiency of Ts cells inhibition function by BM-MSCs were all decreased in patients with ITP. All-trans retinoic acid preconditioning promoted BM-MSC induction of Ts cell percentages and umbilical cord-derived (UC) MSCs efficiently improved ITP Ts cell numbers and dysfunction. In conclusion, defects of BM-MSCs in Ts cell induction are involved in ITP pathogenesis, and exogenous UC-MSCs may be useful for ITP therapy.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Li H, Guan Y, Sun B, et al. Role of bone marrow-derived mesenchymal stem cell defects in CD8+ CD28- suppressor T-lymphocyte induction in patients with immune thrombocytopenia and associated mechanisms. Br J Haematol. 2020. PMID: 32677050. doi:10.1111/bjh.16953

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。